
Pharma Marketing News is the monthly newsletter of the Pharma Marketing Network. It is distributed FREE to registered subscribers via email and the Web.
Subscribe
Editorial & Advisory Board
We accept advertising relevant to the interests of our subscribers. For more information, see:
Media Kit
Published by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
|

Advertising Information |
FAQs |
About Us |
Contact Us |
Privacy Policy
Ramifications of FDA Regulatory Actions Helping FDA Find a New Media Regulatory Pathway
On April 2, 2009, the FDA issued 14 letters informing drug companies that their search engine ads, which included drug brand names and indications but no risk information or fair balance, were in violation of the law. This caught many in the drug industry by surprise because they assumed the "one-click rule" applies; ie, as long as the fair balance information was just one click away -- on another Web page -- such ads are allowed by the FDA. With the 14 letters, FDA disagreed and quashed the "one-click rule."
Arnold Friede, counsel to the law firm McDermott Will & Emery LLP, and former Senior Counsel at Pfizer, believes that there is an opportunity now to make a strong and compelling argument for the adoption of rational regulatory policies by the FDA that address the unique features not only of sponsored links, but of other kinds of new communication tools, such as social media and the like.
This article reviews legal ramifications of FDA enforcement letters and focuses on the FDA's contentious regulation of Internet advertising and what the industry is doing to "help" it find a new path in that arena. Included is a discussion of FDA's draft guidance "Presenting Risk Information in Prescription Drug and Medical Device Promotion" and the relevance of FDA's/FTC's "reasonable consumer standard" to search engine paid promotional drug ads.
Topic headings include:
- Making a Case for New Regulations
- Ramifications of Enforcement Letters
- Effect on Company Valuation
- Advertising May Go Dark
- Profits Could be Affected
- Every Letter Has Another Life in Court
- Organizing the Response
- Cheerios vs. the One-Click Rule: Are FDA's Priorities "Askew?"
- Reaching Consensus
- An Alternative Framework
- The Reasonable Man Standard
- Junk Hides the Gems
- Real Problem is Lack of New Media Guidance
|
Order and pay for this reprint now using your credit card...
ONLY $4.95 Download PDF file immediately after paying:
PMN85-02
Issue: Vol. 8, No. 5: May 2009
Word Count: 3653
Find other articles in related Topic Areas:
Pharma Marketing News |
Subscribe |
Discussion Forums |
Roundtable |
Podcasts |
Blog
Daily News Briefs |
Surveys |
Resources/Links |
Glossary |
Case Studies |
Reports
Pharma Marketing Vendor Directory |
Conference Calendar |
Pharma Jobs
Advertising Information |
FAQs |
About Us |
Privacy Policy
© 2009. VirSci Corporation.
All rights reserved.
|
| Find a Vendor |
Pharma Marketing Vendor Directory
Hundreds of pharmaceutical marketing services vendors, consultants, executive search firms, medical education companies, and other companies servicing the needs of the pharmaceutical industry.
Learn More Access Listings
|
| Network |
Online Discussion & Networking Forums
Network with your peers in the industry, seek help advancing your career, discuss current issues.
Learn More
|
| Advertise |
Promote Your Products and Services
Pharma Marketing Network & Pharma Marketing News provide exceptional permission-based e-marketing opportunities.
Learn More Media Kit
Get Rate Card Click Here
|
| Meet |
Attend Industry Conferences and Seminars
Pharma Marketing News is proud to be a media partner for dozens of industry conferences.
Conference Calendar
Get Your Event Listed Click Here
|
| Find a Job |
Get Help Finding a Job in the Pharma Industry
Post your resume to the Pharma Marketing Network Job Exchange Forum where you can also find help from colleagues.
Employers interested in announcing job openings should contact us.
|
|